首页> 外文期刊>Critical care medicine >Vitamin D -Do our patients need not just a room with a view, but one with sunshine?
【24h】

Vitamin D -Do our patients need not just a room with a view, but one with sunshine?

机译:维生素D-我们的患者不仅需要一个有风景的房间,还需要一个有阳光的房间吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Vitamin D comes in two forms, D_2 (ergocalciferol) and D_3 (cholecalciferol), that have the same chemical structure except that D_2 has a methyl group on Carbon 24 of the parent molecule. D_2 is ingested in foods whereas D_3 can be synthesized in the skin from the action of ultraviolet light on 7-dehydrocholesterol. Both compounds are metabolically inert. The active compound is the product of two chemical reactions-the first occurs in the liver mediated by 25-hydrox-ylase which forms 25-hydroxyvitamin D or 25OHD, and the second in the kidney where 1alpha-hydroxylase converts 25OHD to the biologically active hormone 1,25(OH)_2 vitamin D (calcitriol), active in the regulation of serum calcium and phosphate levels. 25OHD is carried in the bloodstream by vitamin D binding protein (DBP). Following its synthesis in the kidney, 1,25(OH)_2, calcitriol, is transported to its sites of action by the same DBP. Even though calcitriol is the biologically active mol- ecule, most studies of the effects of vitamin D have measured its precursor, 25OHD. Other than an additional methyl group on Carbon 24 there is no known difference between 25OHD derived from ergocalciferol (25OH vitamin D_2) or from cholecalciferol (25OH vitamin D_3), and therefore, these observational studies focus on total 25OHD levels. 25OHD bound to DBP circulates in the blood and when calcium levels decrease, or for other unknown reasons, the 25OHD is taken up by the kidney and hydroxylated to the biologically active calcitriol. The process is tightly controlled and calcitriol is not produced in the kidney unless there is a need.
机译:维生素D有两种形式,即D_2(麦角钙化醇)和D_3(胆钙化醇),它们的化学结构相同,只是D_2在母体分子的碳24上具有甲基。 D_2被摄入食物中,而D_3可以通过紫外线对7-脱氢胆固醇的作用在皮肤中合成。两种化合物都是代谢惰性的。活性化合物是两个化学反应的产物-第一个发生在肝脏中,由25-羟化酶介导,形成25-羟基维生素D或25OHD,第二个发生在肾脏中,其中1α-羟化酶将25OHD转化为生物活性激素1,25(OH)_2维生素D(骨化三醇),对调节血清钙和磷酸盐水平有效。维生素D结合蛋白(DBP)在血液中携带25OHD。在肾脏中合成后,1,25(OH)_2钙三醇被同一DBP转运至其作用部位。尽管骨化三醇是具有生物活性的分子,但大多数有关维生素D作用的研究都测量了其前体25OHD。除了碳24上的另一个甲基外,麦角钙化甾醇(25OH维生素D_2)或胆钙化甾醇(25OH维生素D_3)衍生的25OHD之间没有已知的差异,因此,这些观察性研究集中在总25OHD水平上。与DBP结合的25OHD在血液中循环,并且当钙水平降低或出于其他未知原因时,25OHD被肾脏吸收并羟基化为生物活性骨化三醇。严格控制该过程,除非需要,否则不会在肾中产生骨化三醇。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号